BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Egalet 

Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Egalet Provides Commercial Update On SPRIX And OXAYDO 3/25/2015 6:24:00 AM
Egalet Earns $10 Million Milestone Payment Triggered By Advancement Of Shionogi, Inc.'s Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's GuardianTechnology 3/17/2015 7:06:26 AM
Egalet Reports Full Year 2014 Financial Results 3/16/2015 9:46:50 AM
Egalet Accelerates Development Of Abuse-Deterrent Morphine Egalet-001 And Plans To File New Drug Application In The Fourth Quarter 3/11/2015 6:59:44 AM
Egalet To Release 2014 Fourth Quarter And Year-End Financial Results On March 16, 2015 And To Host Conference Call And Webcast To Discuss Commercial Launch On March 25, 2015 3/9/2015 8:13:42 AM
Egalet To Present At Upcoming Conferences In February 2/2/2015 11:59:47 AM
Egalet Announces Positive Top-Line Results From Oral Human Abuse Liability Study Of Abuse-Deterrent Morphine, Egalet-001 1/22/2015 7:55:22 AM
Egalet Appoints Deanne F. Melloy As Chief Commercial Officer 1/9/2015 7:48:44 AM
Egalet Acquires/Licenses Two Innovative Approved Pain Products 1/8/2015 7:56:34 AM
Egalet Reports Third Quarter 2014 Financial Results And Provides Business Update 11/12/2014 7:31:39 AM
12345